Company: APAD
Filing Date: 2025-07-09
Form Type: S-1/A
Source: 0001213900-25-062242
Chunk: 459

Company: AParadise Acquisition Corp.
Filing Date: 2025-07-09
Form: S-1/A
Chunk 459
---
 size of this offering would be a maximum of 23,000,000 units if the underwriters’ over -allotmentoption is exercised in full and therefore that such founder

II-1

shares would represent 25% of the outstanding shares after this offering. Up to 1,000,000 of these shares will be surrendered for no consideration depending on the extent to which the underwriters’ over -allotmentoption is exercised. Our sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our sponsor is to act as the company’s sponsor in connection with this offering. The limited liability company agreement of our sponsor provides that its shares may only be transferred to our officers or directors or other persons affiliated with our sponsor, or in connection with estate planning transfers. Our sponsor and CCM, the representative of the underwriters, have committed to, pursuant to written agreements, purchase an aggregate of 600,000 private placement units (or 660,000 private placement units if the underwriters’ over -allotmentoption is exercised in full), in a private placement that will close simultaneously with the closing of this offering. Of those 600,000 private placement units (or 660,000 private placement units if the underwriters’ over -allotmentoption is exercised in full), the Sponsor has agreed to purchase 400,000 private placement units (or 430,000 private placement units if the underwriters’ over -allotmentoption is exercised in full) and CCM has agreed to purchase 200,000 private placement units (or 230,000 private placement units if the underwriters’ over -allotmentoption is exercised in full). The private placement units will also be worthless if we do not complete our initial business combination. This purchase will take place on a private placement basis simultaneously with the completion of our initial public offering. This issuance will be made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. No underwriting discounts or commissions were paid with respect to such sales. Item 16. Exhibits and Financial Statement Schedules. Exhibit Index

| Exhibit No. |     | Description                                                                                                                         |
| 1.1**       |     | Form of Underwriting Agreement.                                                                                                     |
| 3.1**       |     | Memorandum and Articles of Association.                                                                                             |
|